REPORT ID 3825

EMEA (Europe, Middle East and Africa) Retinoic Acid Receptor Gamma Market Report 2017

Publish Date
14-Dec-17
Pages
100
Format
Electronic (PDF)

In this report, the EMEA Retinoic Acid Receptor Gamma market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K Units), revenue (Million USD), market share and growth rate of Retinoic Acid Receptor Gamma for these regions, from 2012 to 2022 (forecast)
    Europe: Germany, France, UK, Russia, Italy and Benelux;
    Middle East: Saudi Arabia, Israel, UAE and Iran;
    Africa: South Africa, Nigeria, Egypt and Algeria.

EMEA Retinoic Acid Receptor Gamma market competition by top manufacturers/players, with Retinoic Acid Receptor Gamma sales volume (K Units), price (USD/Unit), revenue (Million USD) and market share for each manufacturer/player; the top players including
    3SBio Inc
    Boehringer Ingelheim GmbH
    Clementia Pharmaceuticals Inc
    Galderma SA
    Lee's Pharmaceutical Holdings Ltd
    Phosphagenics Ltd
    Promius Pharma LLC
    Sol-Gel Technologies Ltd
    Valeant Pharmaceuticals International Inc

On the basis of product, this report displays the sales volume, revenue, product price, market share and growth rate of each type, primarily split into
    Alitretinoin
    Bexarotene
    Palovarotene
    Tretinoin
    Others

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
    Dernatology
    Musculoskeletal Disorder
    Immunology
    Ophthalmology
    Others

If you have any special requirements, please let us know and we will offer you the report as you want.

 
			   
Table of Contents

EMEA (Europe, Middle East and Africa) Retinoic Acid Receptor Gamma Market Report 2017
1 Retinoic Acid Receptor Gamma Overview
    1.1 Product Overview and Scope of Retinoic Acid Receptor Gamma
    1.2 Classification of Retinoic Acid Receptor Gamma
        1.2.1 EMEA Retinoic Acid Receptor Gamma Market Size (Sales) Comparison by Type (2012-2022)
        1.2.2 EMEA Retinoic Acid Receptor Gamma Market Size (Sales) Market Share by Type (Product Category) in 2016
        1.2.3 Alitretinoin
        1.2.4 Bexarotene
        1.2.5 Palovarotene
        1.2.6 Tretinoin
        1.2.7 Others
    1.3 EMEA Retinoic Acid Receptor Gamma Market by Application/End Users
        1.3.1 EMEA Retinoic Acid Receptor Gamma Sales (Volume) and Market Share Comparison by Application (2012-2022
        1.3.2 Dernatology
        1.3.3 Musculoskeletal Disorder
        1.3.4 Immunology
        1.3.5 Ophthalmology
        1.3.6 Others
    1.4 EMEA Retinoic Acid Receptor Gamma Market by Region
        1.4.1 EMEA Retinoic Acid Receptor Gamma Market Size (Value) Comparison by Region (2012-2022)
        1.4.2 Europe Status and Prospect (2012-2022)
        1.4.3 Middle East Status and Prospect (2012-2022)
        1.4.4 Africa Status and Prospect (2012-2022)
    1.5 EMEA Market Size (Value and Volume) of Retinoic Acid Receptor Gamma (2012-2022)
        1.5.1 EMEA Retinoic Acid Receptor Gamma Sales and Growth Rate (2012-2022)
        1.5.2 EMEA Retinoic Acid Receptor Gamma Revenue and Growth Rate (2012-2022)

2 EMEA Retinoic Acid Receptor Gamma Competition by Manufacturers/Players/Suppliers, Region, Type and Application
    2.1 EMEA Retinoic Acid Receptor Gamma Market Competition by Players/Manufacturers
        2.1.1 EMEA Retinoic Acid Receptor Gamma Sales Volume and Market Share of Major Players (2012-2017)
        2.1.2 EMEA Retinoic Acid Receptor Gamma Revenue and Share by Players (2012-2017)
        2.1.3 EMEA Retinoic Acid Receptor Gamma Sale Price by Players (2012-2017)
    2.2 EMEA Retinoic Acid Receptor Gamma (Volume and Value) by Type/Product Category
        2.2.1 EMEA Retinoic Acid Receptor Gamma Sales and Market Share by Type (2012-2017)
        2.2.2 EMEA Retinoic Acid Receptor Gamma Revenue and Market Share by Type (2012-2017)
        2.2.3 EMEA Retinoic Acid Receptor Gamma Sale Price by Type (2012-2017)
    2.3 EMEA Retinoic Acid Receptor Gamma (Volume) by Application
    2.4 EMEA Retinoic Acid Receptor Gamma (Volume and Value) by Region
        2.4.1 EMEA Retinoic Acid Receptor Gamma Sales and Market Share by Region (2012-2017)
        2.4.2 EMEA Retinoic Acid Receptor Gamma Revenue and Market Share by Region (2012-2017)
        2.4.3 EMEA Retinoic Acid Receptor Gamma Sales Price by Region (2012-2017)

3 Europe Retinoic Acid Receptor Gamma (Volume, Value and Sales Price), by Players, Countries, Type and Application
    3.1 Europe Retinoic Acid Receptor Gamma Sales and Value (2012-2017)
        3.1.1 Europe Retinoic Acid Receptor Gamma Sales Volume and Growth Rate (2012-2017)
        3.1.2 Europe Retinoic Acid Receptor Gamma Revenue and Growth Rate (2012-2017)
    3.2 Europe Retinoic Acid Receptor Gamma Sales and Market Share by Type
    3.3 Europe Retinoic Acid Receptor Gamma Sales and Market Share by Application
    3.4 Europe Retinoic Acid Receptor Gamma Sales Volume and Value (Revenue) by Countries
        3.4.1 Europe Retinoic Acid Receptor Gamma Sales Volume by Countries (2012-2017)
        3.4.2 Europe Retinoic Acid Receptor Gamma Revenue by Countries (2012-2017)
        3.4.3 Germany Retinoic Acid Receptor Gamma Sales and Growth Rate (2012-2017)
        3.4.4 France Retinoic Acid Receptor Gamma Sales and Growth Rate (2012-2017)
        3.4.5 UK Retinoic Acid Receptor Gamma Sales and Growth Rate (2012-2017)
        3.4.6 Russia Retinoic Acid Receptor Gamma Sales and Growth Rate (2012-2017)
        3.4.7 Italy Retinoic Acid Receptor Gamma Sales and Growth Rate (2012-2017)
        3.4.8 Benelux Retinoic Acid Receptor Gamma Sales and Growth Rate (2012-2017)

4 Middle East Retinoic Acid Receptor Gamma (Volume, Value and Sales Price), by Region, Type and Application
    4.1 Middle East Retinoic Acid Receptor Gamma Sales and Value (2012-2017)
        4.1.1 Middle East Retinoic Acid Receptor Gamma Sales Volume and Growth Rate (2012-2017)
        4.1.2 Middle East Retinoic Acid Receptor Gamma Revenue and Growth Rate (2012-2017)
    4.2 Middle East Retinoic Acid Receptor Gamma Sales and Market Share by Type
    4.3 Middle East Retinoic Acid Receptor Gamma Sales and Market Share by Application
    4.4 Middle East Retinoic Acid Receptor Gamma Sales Volume and Value (Revenue) by Countries
        4.4.1 Middle East Retinoic Acid Receptor Gamma Sales Volume by Countries (2012-2017)
        4.4.2 Middle East Retinoic Acid Receptor Gamma Revenue by Countries (2012-2017)
        4.4.3 Saudi Arabia Retinoic Acid Receptor Gamma Sales and Growth Rate (2012-2017)
        4.4.4 Israel Retinoic Acid Receptor Gamma Sales and Growth Rate (2012-2017)
        4.4.5 UAE Retinoic Acid Receptor Gamma Sales and Growth Rate (2012-2017)
        4.4.6 Iran Retinoic Acid Receptor Gamma Sales and Growth Rate (2012-2017)

5 Africa Retinoic Acid Receptor Gamma (Volume, Value and Sales Price) by Players, Countries, Type and Application
    5.1 Africa Retinoic Acid Receptor Gamma Sales and Value (2012-2017)
        5.1.1 Africa Retinoic Acid Receptor Gamma Sales Volume and Growth Rate (2012-2017)
        5.1.2 Africa Retinoic Acid Receptor Gamma Revenue and Growth Rate (2012-2017)
    5.2 Africa Retinoic Acid Receptor Gamma Sales and Market Share by Type
    5.3 Africa Retinoic Acid Receptor Gamma Sales and Market Share by Application
    5.4 Africa Retinoic Acid Receptor Gamma Sales Volume and Value (Revenue) by Countries
        5.4.1 Africa Retinoic Acid Receptor Gamma Sales Volume by Countries (2012-2017)
        5.4.2 Africa Retinoic Acid Receptor Gamma Revenue by Countries (2012-2017)
        5.4.3 South Africa Retinoic Acid Receptor Gamma Sales and Growth Rate (2012-2017)
        5.4.4 Nigeria Retinoic Acid Receptor Gamma Sales and Growth Rate (2012-2017)
        5.4.5 Egypt Retinoic Acid Receptor Gamma Sales and Growth Rate (2012-2017)
        5.4.6 Algeria Retinoic Acid Receptor Gamma Sales and Growth Rate (2012-2017)

6 EMEA Retinoic Acid Receptor Gamma Manufacturers/Players Profiles and Sales Data
    6.1 3SBio Inc
        6.1.1 Company Basic Information, Manufacturing Base and Competitors
        6.1.2 Retinoic Acid Receptor Gamma Product Type, Application and Specification
            6.1.2.1 Product A
            6.1.2.2 Product B
        6.1.3 3SBio Inc Retinoic Acid Receptor Gamma Sales, Revenue, Price and Gross Margin (2012-2017)
        6.1.4 Main Business/Business Overview
    6.2 Boehringer Ingelheim GmbH
        6.2.1 Company Basic Information, Manufacturing Base and Competitors
        6.2.2 Retinoic Acid Receptor Gamma Product Type, Application and Specification
            6.2.2.1 Product A
            6.2.2.2 Product B
        6.2.3 Boehringer Ingelheim GmbH Retinoic Acid Receptor Gamma Sales, Revenue, Price and Gross Margin (2012-2017)
        6.2.4 Main Business/Business Overview
    6.3 Clementia Pharmaceuticals Inc
        6.3.1 Company Basic Information, Manufacturing Base and Competitors
        6.3.2 Retinoic Acid Receptor Gamma Product Type, Application and Specification
            6.3.2.1 Product A
            6.3.2.2 Product B
        6.3.3 Clementia Pharmaceuticals Inc Retinoic Acid Receptor Gamma Sales, Revenue, Price and Gross Margin (2012-2017)
        6.3.4 Main Business/Business Overview
    6.4 Galderma SA
        6.4.1 Company Basic Information, Manufacturing Base and Competitors
        6.4.2 Retinoic Acid Receptor Gamma Product Type, Application and Specification
            6.4.2.1 Product A
            6.4.2.2 Product B
        6.4.3 Galderma SA Retinoic Acid Receptor Gamma Sales, Revenue, Price and Gross Margin (2012-2017)
        6.4.4 Main Business/Business Overview
    6.5 Lee's Pharmaceutical Holdings Ltd
        6.5.1 Company Basic Information, Manufacturing Base and Competitors
        6.5.2 Retinoic Acid Receptor Gamma Product Type, Application and Specification
            6.5.2.1 Product A
            6.5.2.2 Product B
        6.5.3 Lee's Pharmaceutical Holdings Ltd Retinoic Acid Receptor Gamma Sales, Revenue, Price and Gross Margin (2012-2017)
        6.5.4 Main Business/Business Overview
    6.6 Phosphagenics Ltd
        6.6.1 Company Basic Information, Manufacturing Base and Competitors
        6.6.2 Retinoic Acid Receptor Gamma Product Type, Application and Specification
            6.6.2.1 Product A
            6.6.2.2 Product B
        6.6.3 Phosphagenics Ltd Retinoic Acid Receptor Gamma Sales, Revenue, Price and Gross Margin (2012-2017)
        6.6.4 Main Business/Business Overview
    6.7 Promius Pharma LLC
        6.7.1 Company Basic Information, Manufacturing Base and Competitors
        6.7.2 Retinoic Acid Receptor Gamma Product Type, Application and Specification
            6.7.2.1 Product A
            6.7.2.2 Product B
        6.7.3 Promius Pharma LLC Retinoic Acid Receptor Gamma Sales, Revenue, Price and Gross Margin (2012-2017)
        6.7.4 Main Business/Business Overview
    6.8 Sol-Gel Technologies Ltd
        6.8.1 Company Basic Information, Manufacturing Base and Competitors
        6.8.2 Retinoic Acid Receptor Gamma Product Type, Application and Specification
            6.8.2.1 Product A
            6.8.2.2 Product B
        6.8.3 Sol-Gel Technologies Ltd Retinoic Acid Receptor Gamma Sales, Revenue, Price and Gross Margin (2012-2017)
        6.8.4 Main Business/Business Overview
    6.9 Valeant Pharmaceuticals International Inc
        6.9.1 Company Basic Information, Manufacturing Base and Competitors
        6.9.2 Retinoic Acid Receptor Gamma Product Type, Application and Specification
            6.9.2.1 Product A
            6.9.2.2 Product B
        6.9.3 Valeant Pharmaceuticals International Inc Retinoic Acid Receptor Gamma Sales, Revenue, Price and Gross Margin (2012-2017)
        6.9.4 Main Business/Business Overview

7 Retinoic Acid Receptor Gamma Manufacturing Cost Analysis
    7.1 Retinoic Acid Receptor Gamma Key Raw Materials Analysis
        7.1.1 Key Raw Materials
        7.1.2 Price Trend of Key Raw Materials
        7.1.3 Key Suppliers of Raw Materials
        7.1.4 Market Concentration Rate of Raw Materials
    7.2 Proportion of Manufacturing Cost Structure
        7.2.1 Raw Materials
        7.2.2 Labor Cost
        7.2.3 Manufacturing Expenses
    7.3 Manufacturing Process Analysis of Retinoic Acid Receptor Gamma

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
    8.1 Retinoic Acid Receptor Gamma Industrial Chain Analysis
    8.2 Upstream Raw Materials Sourcing
    8.3 Raw Materials Sources of Retinoic Acid Receptor Gamma Major Manufacturers in 2016
    8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
    9.1 Marketing Channel
        9.1.1 Direct Marketing
        9.1.2 Indirect Marketing
        9.1.3 Marketing Channel Development Trend
    9.2 Market Positioning
        9.2.1 Pricing Strategy
        9.2.2 Brand Strategy
        9.2.3 Target Client
    9.3 Distributors/Traders List

10 Market Effect Factors Analysis
    10.1 Technology Progress/Risk
        10.1.1 Substitutes Threat
        10.1.2 Technology Progress in Related Industry
    10.2 Consumer Needs/Customer Preference Change
    10.3 Economic/Political Environmental Change

11 EMEA Retinoic Acid Receptor Gamma Market Forecast (2017-2022)
    11.1 EMEA Retinoic Acid Receptor Gamma Sales, Revenue and Price Forecast (2017-2022)
        11.1.1 EMEA Retinoic Acid Receptor Gamma Sales and Growth Rate Forecast (2017-2022)
        11.1.2 EMEA Retinoic Acid Receptor Gamma Revenue and Growth Rate Forecast (2017-2022)
        11.1.3 EMEA Retinoic Acid Receptor Gamma Price and Trend Forecast (2017-2022)
    11.2 EMEA Retinoic Acid Receptor Gamma Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.3 Europe Retinoic Acid Receptor Gamma Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.4 Middle Eastt Retinoic Acid Receptor Gamma Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.5 Africa Retinoic Acid Receptor Gamma Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.6 EMEA Retinoic Acid Receptor Gamma Sales Forecast by Type (2017-2022)
    11.7 EMEA Retinoic Acid Receptor Gamma Sales Forecast by Application (2017-2022)

12 Research Findings and Conclusion

13 Appendix
    13.1 Methodology/Research Approach
        13.1.1 Research Programs/Design
        13.1.2 Market Size Estimation
        13.1.3 Market Breakdown and Data Triangulation
    13.2 Data Source
        13.2.1 Secondary Sources
        13.2.2 Primary Sources
    13.3 Disclaimer